These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36651155)

  • 1. Long-acting PEGylated growth hormone in children with idiopathic short stature: time to reconsider our diagnostic and treatment policy?
    Wit JM; Joustra SD
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of treatment with recombinant human growth hormone (rhGH) on linear growth and adult height in children with idiopathic short stature (ISS): a systematic review and meta-analysis.
    Paltoglou G; Dimitropoulos I; Kourlaba G; Charmandari E
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1577-1588. PubMed ID: 33035189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of growth hormone treatment of children with idiopathic short stature: the US experience.
    Allen DB
    Horm Res Paediatr; 2011; 76 Suppl 3():45-7. PubMed ID: 21912165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting PEGylated growth hormone in children with idiopathic short stature.
    Luo X; Zhao S; Yang Y; Dong G; Chen L; Li P; Luo F; Gong C; Xu Z; Xu X; Gong H; Du H; Hou L; Zhong Y; Shi Q; Chen X; Chen X; Xu L; Cheng R; Su C; Ma Y; Xu L; Zhang L; Lu H
    Eur J Endocrinol; 2022 Nov; 187(5):709-718. PubMed ID: 36130048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
    Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Effectiveness and Comparable Safety in Biweekly
    Sun C; Lu B; Liu Y; Zhang Y; Wei H; Hu X; Hu P; Zhao Q; Liu Y; Ye K; Wang K; Gu Z; Liu Z; Ye J; Zhang H; Zhu H; Jiang Z; Liu Y; Wan N; Yan C; Yin J; Ying L; Huang F; Yin Q; Xi L; Luo F; Cheng R
    Front Endocrinol (Lausanne); 2021; 12():779365. PubMed ID: 34899612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of efficacy and safety of long-acting PEGylated recombinant human growth hormone (Jintrolong) for patients with growth hormone deficiency.
    Du H; Wu D; Yi P; Bai X; Luo Y; Yang H; Chen S; Pan H; Zhu H
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):511-517. PubMed ID: 35245011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies.
    Luo X; Hou L; Liang L; Dong G; Shen S; Zhao Z; Gong CX; Li Y; Du ML; Su Z; Du H; Yan C
    Eur J Endocrinol; 2017 Aug; 177(2):195-205. PubMed ID: 28566441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Human Growth Hormone in Idiopathic Short Stature.
    Tao S; Li G; Wang Q; Hu Y
    Indian J Pediatr; 2015 Jul; 82(7):625-8. PubMed ID: 25893526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature.
    Ying YQ; Hou L; Liang Y; Wu W; Luo XP
    Growth Horm IGF Res; 2018; 42-43():80-85. PubMed ID: 30343148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
    Liu HJ; Wang LH; Chen L
    Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone therapy in children with partial growth hormone deficiency. Are we treating the right patients?
    Krukowska-Andrzejczyk B; Kalina M; Kalina-Faska B; Małecka-Tendera E
    Pediatr Endocrinol Diabetes Metab; 2020; 26(2):65-72. PubMed ID: 32564582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the definition and treatment of idiopathic short stature (ISS).
    Pedicelli S; Peschiaroli E; Violi E; Cianfarani S
    J Clin Res Pediatr Endocrinol; 2009; 1(3):105-15. PubMed ID: 21274395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994.
    Root AW; Kemp SF; Rundle AC; Dana K; Attie KM
    J Pediatr Endocrinol Metab; 1998; 11(3):403-12. PubMed ID: 11517956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial.
    Kim J; Suh BK; Ko CW; Lee KH; Shin CH; Hwang JS; Kim HS; Chung WY; Kim CJ; Han HS; Kwon NY; Cho SY; Yoo HW; Jin DK
    J Endocrinol Invest; 2018 Apr; 41(4):475-483. PubMed ID: 29103133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic short stature: definition and treatment].
    Diago Cabezudo JI; Carrascosa Lezcano A; del Valle Núñez CJ; Ferrández Longás A; Gracia Bouthelier R; Pombo Arias M
    An Pediatr (Barc); 2006 Apr; 64(4):360-4. PubMed ID: 16606574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.